Micro Life Sciences Private Limited
About Micro Life Sciences Private Limited
Data last updated: 20 December 2025
Micro Life Sciences Private Limited is a private limited company based in Vapi, Gujarat, India, a subsidiary of Bilakhia Holdings Private Limited. It specialises in medical and laboratory equipment, a part of the broader healthcare sector. Incorporated on 31 May 2006, the company has been in operation for over 20 years.
Registered with ROC Ahmedabad under CIN U24119GJ2006PLC048361.
Capital: an authorised share capital of ₹53.08 Cr and a paid-up capital of ₹5 Cr. Formerly known as Micro Life Sciences Limited and Micro Lifescience Limited. It is led by directors including Vivek Prafulbhai Shah and Pramodkumar Minocha.
Last AGM: 11 August 2025. Financial statements filed for year ended 31 March 2025. Office: Bilakia House Muktanand Marg Chala, Vapi, Gujarat, India – 396191.
As per the financials filed for FY 2025, the company reported a revenue of ₹4,992.15 Cr, a growth of 40% compared to the previous year.
The company has a workforce of approximately 618 employees as per the latest available data. It operates as a subsidiary of Bilakhia Holdings Private Limited.
The company is associated with 2 brands - Myval, Meril. As per MCA filings, the company has open charges of ₹1,237 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media**************
-
Registered AddressBilakia House Muktanand Marg Chala, Vapi, Gujarat, India – 396191
-
IndustryHealthcare, Medical & Laboratory Equipment
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Micro Life Sciences Private Limited
Micro Life Sciences Private Limited has undergone 2 name changes throughout its history. The company was previously known as Micro Life Sciences Limited, and Micro Lifescience Limited. The current legal name is Micro Life Sciences Private Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Micro Life Sciences Private Limited | Current |
| Micro Life Sciences Limited | Previous |
| Micro Lifescience Limited | Previous |
CIN History of Micro Life Sciences Private Limited
Micro Life Sciences Private Limited has one previous CIN (Corporate Identification Number): U24119GJ2006PLC048361. The current CIN is U24119GJ2006PTC048361, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24119GJ2006PTC048361 | Current |
| U24119GJ2006PLC048361 | Previous |
Associated Brands with Micro Life Sciences Private Limited
Micro Life Sciences Private Limited operates two associated brands: Myval and Meril. These brands represent Micro Life Sciences Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Offers a transcatheter aortic heart valve replacement system. | myval.com | |
| Developer of medical devices for surgeries and diagnosis | merillife.com |
Competitors & Alternatives of Micro Life Sciences Private Limited
Brands and companies operating in the same space as Micro Life Sciences Private Limited include GE Healthcare, Medtronic, Boston Scientific and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
|
|
Materials management solutions are provided for healthcare organizations. | Chicago, United States, United States | 1892 |
|
|
Medical equipment for treating over 30 chronic diseases is developed. | Minneapolis, United States, United States | 1949 |
|
|
Wide range of medical devices | Marlborough, United States, United States | 1979 |
|
|
Healthcare solutions are provided by Johnson & Johnson globally. | New Brunswick, United States, United States | 1886 |
|
|
Provider of neuroprotection devices for carotid artery disease | Sunnyvale, United States, United States | 2007 |
|
|
Diagnostic and surgical products for women's healthcare are provided. | Marlborough, United States, United States | 1985 |
|
|
Surgical instruments are manufactured for multiple therapeutic areas. | Utica, United States, United States | 1987 |
|
|
Complex healthcare challenges are addressed through technology solutions by Commure. | San Francisco, United States, United States | 2016 |
|
|
Laser-based and photonics products are manufactured for multiple applications. | Santa Clara, United States, United States | 1966 |
|
|
Biosciences, medication delivery, and renal products are developed and marketed. | Deerfield, United States, United States | 1931 |
Business Activity of Micro Life Sciences Private Limited
Micro Life Sciences Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C13 | Other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities | ********* |
Board of Directors of Micro Life Sciences Private Limited
Micro Life Sciences Private Limited is currently managed by 5 directors, with 10 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vivek Prafulbhai Shah | Whole-Time Director | 13 May 2021 | 5 Years 1 Months | Current |
|
Pramodkumar Minocha
Also directs:
Meril Healthcare Private Limited, Meril Life Sciences India Private Limited, Meril Diagnostics Private Limited and 2 more
|
Whole-Time Director | 31 May 2006 | 20 Years 1 Months | Current |
|
Narendra Ostawal
Also directs:
Nna Cre Properties Llp, Idfc First Bank Limited, Indiafirst Life Insurance Company Limited and 2 more
|
Director | 15 Feb 2024 | 2 Years 4 Months | Current |
| Dinesh Saraf | Whole-Time Director | 01 Jan 2022 | 4 Years 6 Months | Current |
Financials of Micro Life Sciences Private Limited FY 2025 filings available
Micro Life Sciences Private Limited reported revenue of ₹4,992.15 Cr (up 40% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Charges & Borrowings of Micro Life Sciences Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jun 2025 | Others | ₹250 Cr | Open |
| 26 Mar 2025 | Hdfc Bank Limited | ₹188 Cr | Open |
| 01 Jan 2025 | Hdfc Bank Limited | ₹389 Cr | Open |
| 29 Jun 2024 | Others | ₹250 Cr | Open |
| 24 Nov 2023 | Hdfc Bank Limited | ₹100 Cr | Open |
Total charge records: 7 View all charges
Employees and EPFO Compliance at Micro Life Sciences Private Limited
View historical data on people associated with Micro Life Sciences Private Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Micro Life Sciences Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Micro Life Sciences Private Limited
GSTIN & GST Filing Data of Micro Life Sciences Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Micro Life Sciences Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Micro Life Sciences Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Micro Life Sciences Private Limited
MSME Payment Delays by Micro Life Sciences Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Micro Life Sciences Private Limited
Subsidiaries & Group Companies of Micro Life Sciences Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Micro Life Sciences Private Limited with ownership details.
MCA Filings & Documents of Micro Life Sciences Private Limited
MCA Filings & Documents of Micro Life Sciences Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Micro Life Sciences Private Limited
Frequently Asked Questions about Micro Life Sciences Private Limited
Micro Life Sciences Private Limited is an active private limited company in the healthcare sector based in Vapi, Gujarat, India. It was incorporated on 31 May 2006 (20+ years old) and is registered under CIN U24119GJ2006PTC048361. The company has 618 employees.
Micro Life Sciences Private Limited reported revenue of ₹4,992.15 Cr for FY 2025 (up 40.00% YoY).
The current directors of Micro Life Sciences Private Limited are:
- Vivek Prafulbhai Shah
- Pramodkumar Minocha
- Alpesh Mansukhlal Chaniyara
- Narendra Ostawal
- Dinesh Saraf
The primary industry of Micro Life Sciences Private Limited is healthcare. The company specifically operates in medical and laboratory equipment. The company is currently active in this sector.
Micro Life Sciences Private Limited can be reached at the registered office: Bilakia House Muktanand Marg Chala, Vapi, Gujarat, India – 396191.
The authorised capital is ₹53.08 Cr, and the paid-up capital is ₹5 Cr.